Pharmacology of Cognition in Schizotypal Personality Disorder

NCT00353379 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped low enrollment

Conditions

Schizotypal Personality Disorder
Personality Disorders

Interventions

DRUG: Guanfacine
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]